.jpeg)
India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US dollar 2.47 billion in May 2025 from US dollar 2.31 billion in the corresponding month last year, based on Ministry of Commerce and Industry released data.
Alembic Pharmaceuticals Ltd reported on Wednesday, June 18, that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing site, at Karakhadi, Gujarat...
.jpeg)
The Smt. Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, provided a note to address at the Second Policymakers’ Forum, organized by the Indian Pharmacopoeia Commission
 (1).png)
IOL Chemicals and Pharmaceuticals Limited has been honored with a Silver Medal by EcoVadis, achieving a creditable score of 71 and obtaining a position in the 89th percentile among companies evaluated worldwide.
.jpeg)
Shilpa Biocare, an integral Shilpa Medicare subsidiary, has signed a commercial supply contract across Europe with Orion Corporation for its recombinant human albumin, ahead of the Bio International Bio Convention in Boston.
.jpeg)
Parexel, a top-ranked international clinical research organisation (CRO), has formally registered with India's Central Drugs Standard Control Organisation (CDSCO), in line with the newly imposed G.S.R 581(E) regulation.
.jpg)
India is considering imposing a Minimum Import Price (MIP) on critical components of medicines to cut the country's dependence on costlier Chinese imports and spur local production.
 (2).png)
Glenmark Pharmaceuticals has announced that it will shortly introduce zanubrutinib in India, soon after getting its recent approval from the Drugs Controller General of India (DCGI).
 (2).png)
Lupin Limited has obtained approval from the USFDA for its 150 mg, 300 mg, and 600 mg strength Oxcarbazepine ER tablets.
Servier India, the Indian subsidiary of French multinational pharmaceutical company Servier Group, has rolled out Ivosidenib, an oral targeted treatment for IDH1-mutated acute myeloid leukaemia
.jpg)
, CDSCO.jpg)